260 related articles for article (PubMed ID: 15752838)
1. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis.
Maeba S; Otake S; Namikoshi J; Shibata Y; Hayakawa M; Abiko Y; Yamamoto M
Vaccine; 2005 Mar; 23(19):2513-21. PubMed ID: 15752838
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous immunization with an outer membrane protein of Porphyromonas gingivalis without adjuvant elicits marked antibody responses.
Koizumi Y; Kurita-Ochiai T; Yamamoto M
Oral Microbiol Immunol; 2008 Apr; 23(2):131-8. PubMed ID: 18279181
[TBL] [Abstract][Full Text] [Related]
3. Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity.
Zhang T; Hashizume T; Kurita-Ochiai T; Yamamoto M
Biochem Biophys Res Commun; 2009 Dec; 390(3):937-41. PubMed ID: 19852927
[TBL] [Abstract][Full Text] [Related]
4. Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice.
Cai Y; Kurita-Ochiai T; Kobayashi R; Hashizume T; Yamamoto M
J Oral Sci; 2013; 55(2):107-14. PubMed ID: 23748449
[TBL] [Abstract][Full Text] [Related]
5. Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits coaggregation activity of P. gingivalis.
Namikoshi J; Otake S; Maeba S; Hayakawa M; Abiko Y; Yamamoto M
Vaccine; 2003 Dec; 22(2):250-6. PubMed ID: 14615153
[TBL] [Abstract][Full Text] [Related]
6. Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies.
Momoi F; Hashizume T; Kurita-Ochiai T; Yuki Y; Kiyono H; Yamamoto M
Infect Immun; 2008 Jun; 76(6):2777-84. PubMed ID: 18411288
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity.
Liu C; Hashizume T; Kurita-Ochiai T; Fujihashi K; Yamamoto M
Mol Oral Microbiol; 2010 Jun; 25(3):178-89. PubMed ID: 20502628
[TBL] [Abstract][Full Text] [Related]
8. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
[TBL] [Abstract][Full Text] [Related]
9. Egg yolk-derived immunoglobulin (IgY) against Porphyromonas gingivalis 40-kDa outer membrane protein inhibits coaggregation activity.
Hamajima S; Maruyama M; Hijiya T; Hatta H; Abiko Y
Arch Oral Biol; 2007 Jul; 52(7):697-704. PubMed ID: 17275778
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice].
Shimauchi H
Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739
[TBL] [Abstract][Full Text] [Related]
11. Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice.
Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
Infect Immun; 2008 Jul; 76(7):2958-65. PubMed ID: 18426881
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to Porphyromonas gingivalis hemagglutinin A and outer membrane protein in chronic periodontitis.
Kobayashi T; Kaneko S; Tahara T; Hayakawa M; Abiko Y; Yoshie H
J Periodontol; 2006 Mar; 77(3):364-9. PubMed ID: 16512750
[TBL] [Abstract][Full Text] [Related]
13. Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity.
Yuzawa S; Kurita-Ochiai T; Hashizume T; Kobayashi R; Abiko Y; Yamamoto M
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):265-72. PubMed ID: 22066647
[TBL] [Abstract][Full Text] [Related]
14. Lower antibody response to Porphyromonas gingivalis associated with immunoglobulin G Fcgamma receptor IIB polymorphism.
Honma Y; Sugita N; Kobayashi T; Abiko Y; Yoshie H
J Periodontal Res; 2008 Dec; 43(6):706-11. PubMed ID: 18705654
[TBL] [Abstract][Full Text] [Related]
15. Assessment of outer membrane vesicles of periodontopathic bacterium Porphyromonas gingivalis as possible mucosal immunogen.
Nakao R; Hasegawa H; Dongying B; Ohnishi M; Senpuku H
Vaccine; 2016 Aug; 34(38):4626-4634. PubMed ID: 27461458
[TBL] [Abstract][Full Text] [Related]
16. The r40-kDa outer membrane protein human monoclonal antibody protects against Porphyromonas gingivalis-induced bone loss in rats.
Hamada N; Watanabe K; Tahara T; Nakazawa K; Ishida I; Shibata Y; Kobayashi T; Yoshie H; Abiko Y; Umemoto T
J Periodontol; 2007 May; 78(5):933-9. PubMed ID: 17470029
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity of a monoclonal antibody against a recombinant 40-kDa outer membrane protein of Porphyromonas gingivalis.
Katoh M; Saito S; Takiguchi H; Abiko Y
J Periodontol; 2000 Mar; 71(3):368-75. PubMed ID: 10776923
[TBL] [Abstract][Full Text] [Related]
18. Opsonophagocytic effect of antibody against recombinant conserved 40-kDa outer membrane protein of Porphyromonas gingivalis.
Saito S; Hayakawa M; Takiguchi H; Abiko Y
J Periodontol; 1999 Jun; 70(6):610-7. PubMed ID: 10397516
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.
Puth S; Hong SH; Park MJ; Lee HH; Lee YS; Jeong K; Kang IC; Koh JT; Moon B; Park SC; Rhee JH; Lee SE
Hum Vaccin Immunother; 2017 Dec; 13(12):2794-2803. PubMed ID: 28604268
[TBL] [Abstract][Full Text] [Related]
20. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
